The use of vitamin E in type 2 diabetes mellitus

Clinical and Experimental Hypertension

Volumn 29, Issue 3, 2007, Pages 135-148

  Fardoun, Riham Zein ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; CHROMIUM PICOLINATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; GENE PRODUCT; GLUTATHIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; RAMIPRIL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ABDOMINAL OBESITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CLINICAL TRIAL; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG USE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; REVIEW; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME; VITAMIN E;

EID: 34248369249     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960701361601     Document Type: Review

References (57)

1. Bierman EL. Atherogenesis in diabetes. Arterioscler Thromb. 1992;12:647-656.
2. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews. 2002;23:599-622.
3. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetic Care. 1996;19:257-267.
4. Grodsky GM. Kinetics of insulin secretion: underlying metabolic events in diabetes mellitus. In Diabetes mellitus: a fundamental and clinical text. Le Rioth D, Taylor SI, Olesky JM, eds. Philadelphia, PA: Lippicott Williams and Wilkins; 2000:2-11.
5. DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Review. 1997;5:177-269.
6. Paolisso G, Guigliano D. Oxidative stress and insulin action. Is there a relationship? Diabetologia. 1996;39:357-363.
7. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations. Diabetes. 2003;52:2346-2352.
8. Cross CE, Halliwell B. Oxygen radicals and human disease. Ann Intern Med. 1987;107:526-545.
9. Baynes JW. Role of oxidative stress in development of complication in diabetes. Diabetes. 1991;40:405-412.
10. Matkovics B, Varga SI, Szabo L, Witas H. The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res. 1982;14:77-79.
11. Wohaieb SA, Godin DV. Alteration in tissue antioxidant systems in the spontaneously diabetic (BB) wistar rat. Can J Physiol Pharmacol. 1987;65:2191-2195.
12. Crouch R, Kimsey G, Priest DG, Sarda A, Buse MG. Effects of streptozotocin on erythrocyte and retinal superoxide dismutase. Diabetelogia. 1978;15:53-57.
13. Khan CR, Vicent D, Doria A. Genetics of non insulin dependent type 2 diabetes mellitus. Annu Rev Med. 1996;47:509-531.
14. Lowenstein C, Dinerman JL, Snyder HS. Nitric oxide: a physiological messenger. Ann Intern Med. 1994;120:227-237.
15. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin dependent diabetes. J Clin Inves. 1992,90:2548-2554.
16. Ceriello A. New insights on oxidative stress and diabetic complications may lead to causal antioxidant therapy. Diabetes Care. 2003;26:1589-1593.
17. Paolisso G, Tagliamonte MR, Marfella R, Verrazzo G, D'Onofrio F, Giugliano D. L. arginine but not D. arginine stimulates insulin mediated glucose uptake. Metabolism. 1997;46:1068-1073.
18. Harrison DG. Endothelial dysfunction in the coronary microcirculation: a new clinical entity or an experimental finding? J Clin Inves. 1993;91:1-2.
19. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK. Antioxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non diabetic and STZ-diabetic rats. Diabetologia. 1994;37:449-459.
20. Cameron NE and Cotter MA. Neurovascular dysfunction in diabetic rats: potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J Clin Inves. 1995;96:1159-1163.
21. Kanwar N, Wallner EI. Current status of the structural and functional basis of glomerular filtration and preotienuria. Semin Nephrol. 1991;11:390-413.
22. Kashihara N, Watanabe Y, Makino H, Wallner EI, Kanwar YS. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc Natl Acad Sci USA. 1992;89:6309-6313.
23. Melhem MF, Craven PA, Derubertis FR. Effects of dietary supplementation of alpha lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Neph. 2001;12:124-133.
24. Bursell SE, Clermont AC, Aiello LP. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care. 1992;22:1245-1251.
25. Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T, Cardia L, Altomare E. Oxidative retinal products and ocular damages in diabetic patients. Free Radic Biol Med. 1998;25:369-372.
26. th ed. Baltimore: Williams & Wilkins, 1999.
27. Salonen JT, Nyyssõnen K, Tuomainen T-P, Mäenpää PH, Korpela H, Kaplan GA, Lynch J, Helmrich SP, Salonen R. Increased risk for non dependent diabetes mellitus at low plasma vitamin E concentrations: a four year study in men. Brit Med J. 1995;311:1124-1127.
28. Polidori MC, Mecocci P, Stahl W, Parente B, Cecchetti R, Cherubini A, Cao P, Sies H, Senin U. Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabetes Metab Res Rev. 2000;16:15-19.
29. Sharma A, Kharb S, Chugh SN, Kakkar R, Singh GP. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism. 2000;49:160-162.
30. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk for CAD in men. N Eng J Med. 1993;328:1450-1456.
31. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet. 1996;347:781-786.
32. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high risk patients. The Heart Outcome Prevention Evaluation Study. N Eng J Med. 2000;342:154-160.
33. Reaven PD, Herold DA, Barnett J, Edelman S. Effects of vitamin E susceptibility of low density lipoprotein and low density subfractions to oxidation and protein glycation in NIDDM. Diabetes Care. 1995;18:807-816.
34. Gomez-Perez FJ, Valles-Sanchez VE, Lopez-Alvarenga JC, Choza-Romero R, Ibarra Pascuali JJ, Gonzalez Orellana R, Perez Ortiz OB, Rodriguez Padilla EG, Aguilar Salinas CA, Rull JA. Vitamin E modifies neither fructosamine nor HbA1c levels in poorly controlled diabetes. Rev Inv Clin. 1996;48:421-424.
35. Devaraj S, Jialal I. Low density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrvascualr complications. Circulation. 2000;102:191-196.
36. Andrew R, Skyrme-Jones P, O'Brien RC, Berry KL, Meredith IT. Vitamin E supplementation improves endothelial function in type 1 diabetes mellitus: a randomized, placebo controlled study. J Am Coll Cardiol. 2000;36:94-102.
37. Tutuncu NB, Bayraktar M, Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes. Diabetes Care. 1998;21:1915-1918.
38. Jain SK, McVie R, Jaramillo JJ, Palmer M, Smith T. Effect of modest vitamin E supplementation on blood glycated hemoglobin and triglyceride levels and red cell indices in type 1 diabetic patients. J Am Coll Nutr. 1996;15:458-461.
39. Skrha J, Sindelka G, Kvasnicka J, Hilgertova J. Insulin action and fibrinolysis influenced by vitamin E in obese type 2 diabetes mellitus. Diab Res Clin Prac. 1999;4:27-33.
40. Connell B. Select vitamins and minerals in the management of diabetes. Diabetes Spectrum. 2001;14:133-148.
41. Skyrme-Jones RA, O'Brein RC, Berry KL, Meredith IT. Vitamin E supplementation improves endothelial function in type 1 diabetes mellitus: a randomized, placebo-controlled study. J Am Coll Cardiol. 2000;36: 94-102.
42. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Keaney JF Jr, Creager MA. Oral antioxidant therapy improves endothelial function in type 1 but not type 2 diabetes mellitus. Am J Physiol. 2003;285:H2392-H2398.
43. Gaede P, Poulsen HE, Parving HH, Pederson O. Double-blind, randomized study of the effect of the combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients. Diabet Med. 2001;18:756-760.
44. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Eng J Med. 2000;342:154-160.
45. Boaz M, Smentana S, Weinstein T, Matas Z, Gafter U, Laina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M. Secondary prevention with the antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomized placebo-controlled trial. Lancet. 2000;356:1213-1218.
46. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pederson O. Mutilfactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
47. Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Togononi G, Nicolucci A. Primary prevention of cardiovascular events with low dose aspirin and vitamin E in type two diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care. 2003;26:3264-3272.
48. Lonn EM, Yusuf S, Dzavik V, Doris CI, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley WA, Teo KK. Effects of ramipril and vitamin E in atherosclerosis. The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation. 2001;103:919-925.
49. Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JFE, Gerstein HC. Effects of vitamin E on cardiovascular and microvascular outcomes in high risk patients with diabetes. Results of HOPE study and MICRO-HOPE Substudy. Diabetes Care. 2002;25:1919-1927.
50. Regani M, Malfatto G, Pierini S. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst. 1988;23:143-153.
51. Manzella D, Michelangela B, Emilia R, Paolisso G. Chronic administration of pharmacological doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. Am J Clin Nutr. 2001;73:1052-1057.
52. Montonen J, Knekt P, Jarvinen R, Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care. 2004;27:362-366.
53. Johansen JS, Harris A, Rychly DJ, Ergul A. Oxidative stress and the us of antioxidants in diabetes: linking basic science to clinical practice. Cardiovascular Diabetology. 2005;4:1-11.
54. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio F. Pharmacological doses of vitamin E improve insulin action in healthy subjects and non insulin dependent diabetic patients. Am J Clin Nutr. 1993;57:650-656.
55. Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Romiti A, Giovannini C, Lucentini L, Matteoli MC, Crino A, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Suppa G, Sulli N, De Mattia G, Faldetta MR. Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin dependent diabetes. Eur Journal Endocrinol. 1997;137:234-239.
56. Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein glucosylation in diabetes. New prospect for prevention of diabetic complications. Diabetes Care. 1991;14:68-72.
57. Paolisso G, D'Amore A, Galzerano D, Balbi V, Giugliano D, Varricchio M, D'Onofrio F. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type 2 diabetic patients. Diabetes Care. 1993;16:1433-1437.